Beware of changing the packaging of drugs to avoid

Beware of changing the packaging of drugs to avoid price reduction

since 1998, the phenomenon of continuous price reduction sales has appeared in China's drug market under the intervention of the state, and the sharp price reduction of drugs has aroused public but widespread concern. China has been able to produce tens of thousands of drug varieties, more than 6700 manufacturing enterprises, more than 17000 wholesale enterprises and more than 120000 retail pharmacies. The oversupply of products and the intense market competition are obvious. However, some of our drug manufacturers do not spend their mind and energy on the development of new products and the improvement of drug quality, but have the idea of drug packaging. After each price reduction, they often re declare the price by changing the packaging and name to avoid the price reduction. After the change, the price rises back to its original position, or even higher. In this way, the benefits of drug price reduction are naturally difficult to reach consumers

there are countless examples:

-- ampicillin, a drug commonly used in children's colds, used to cost 10 yuan a bottle, and children took it with good results. After the price reduction, this drug was quickly replaced with "amoxicillin". The pharmacological formula and production process were the same as the former, and (5) the name of unstable loading was changed. It not only avoided the price cut, but also cost more than 2 yuan

-- an anti-inflammatory drug for the treatment of urinary system infection“ × "Yanqing" is actually the original Urotropine tablets, which are among the drugs with reduced prices. The price of this anti-inflammatory drug used to be about 30 cents per tablet, but after changing the new packaging, the price increased to more than 1 yuan per tablet

- "roxithromycin" is easy to remember and understand, and its anti-inflammatory effect is good. Ordinary people can say that no one knows it. There are dozens of pharmaceutical factories producing this common drug in China. In order to avoid price reduction, many pharmaceutical factories have changed the packaging and name of drugs

if you pay more attention, you will find that whenever the state introduces a drug price reduction policy, colorful new drugs and special drugs will appear around us, especially in newspapers and TV advertisements. Most of these drugs have luxurious packaging, strange names and high prices. But the common people generally reflect that they can't afford to buy medicine now! Drugs are getting cheaper and more expensive, the packaging is getting more and more fancy, the name is getting more and more based on the elasticity of the spring. After using for a period of time, fatigue will occur, which is more and more strange, but the efficacy is getting worse and worse. Take children with colds and fever for example. Now, when you go to the hospital, fiveorsix bottles fall out, or even a dozen, and you can't guarantee to cure your child's disease. Many parents are puzzled and ask the doctor: in the past, if you had a cold when you were a child, you would be fine if you took some medicine. Nowadays, it's not good to spend more money and take more injections. What's wrong with these drugs

it turns out that there is a terrible "packaging" inside story behind these drugs. Changing the name of the old medicine, or slightly modifying the ingredients of the old medicine without increasing the efficacy, will easily become a "new medicine". Then, carry out luxurious packaging and advertising, and the price of the medicine will naturally double. And consumers also think it is a new and good drug. Another situation is that some pharmaceutical factories have used their brains on the packaging because of the long-term unsalable drugs. They try to make the outer packaging of drugs eye-catching and the production date as vague as possible, which is easy to give people the illusion that this is a new product. Then, to reduce the dose, we need to control the filler - the filler spacing is greater than the force range: ferrous sulfate, a commonly used drug for iron deficiency anemia, used to buy 100 tablets for 1 yuan, but now it can no longer be seen in hospitals, and it is replaced by commercial drugs“ × "Nade", the price of 7 tablets per plate is more than 20 yuan. Its composition is ferrous sulfate, and the dose is not increased compared with the previous one

the two killer maces of drug manufacturers "changing packaging and name" have successfully evaded the regulation of drug price reduction, and also opened countless sales channels. Coupled with the dealers' stripping from the middle market, the drug price has soared. The so-called "three-year drug dealers, 100000 snowflakes and silver", just pity the people